# PerceptiMed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/perceptimed

- Industry: Healthcare IT
- Headquarters: Mountain View, US
- Website: www.perceptimed.com
- Total disclosed funding: $5.3M
- Latest round: Series A (Mar 25, 2015)
- Investors on record: 2

## About

Founded in 2011 and headquartered in Mountain View, US, PerceptiMed, Inc., specializes in developing diagnostic tools for ophthalmology. In September 2018, PerceptiMed, Inc. raised USD 2.067 million in Series C. The company is led by CEOs Dan Gordon and Frank Starn. PerceptiMed, Inc., specializes in solutions focused on improving medical practices, particularly in ophthalmology. The company offers advanced diagnostic tools and software that assist practitioners in diagnosing and monitoring eye health, resolving issues accurate patient data and streamlined workflows. The firm serves various clients such as hospitals and private clinics in North America and Europe. PerceptiMed, Inc., generates revenue through direct sales of its diagnostic products and potential subscription services for its software. Revenue is generated by partnerships with healthcare institutions seeking solutions for patient management and diagnostic accuracy.

## Funding rounds

- Series A, Mar 25, 2015, $3M — Latterell Venture Partners, Easton Capital Investment Group
- Series A, Sep 19, 2014, $2.4M — Latterell Venture Partners, Easton Capital Investment Group

## Investors

- Latterell Venture Partners (https://capitalatlas.ai/funds/latterell-venture-partners) — Series A
- Easton Capital Investment Group (https://capitalatlas.ai/funds/easton-capital-investment-group) — Series A